Publicaciones en las que colabora con Félix Roberto Elortza Basterrika (12)

2024

  1. Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1

    JHEP Reports, Vol. 6, Núm. 1

  2. Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway

    Cell Reports Medicine, Vol. 5, Núm. 7

2023

  1. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. Neddylation tunes peripheral blood mononuclear cells immune response in COVID-19 patients

    Cell Death Discovery, Vol. 8, Núm. 1

  2. The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes

    Communications Biology, Vol. 5, Núm. 1

2021

  1. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis

    Molecular Metabolism, Vol. 53

2020

  1. Multi‐omics integration highlights the role of ubiquitination in ccl4‐induced liver fibrosis

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-19

2019

  1. Sumo-binding entities (Subes) as tools for the enrichment, isolation, identification, and characterization of the sumo proteome in liver cancer

    Journal of Visualized Experiments, Vol. 2019, Núm. 153

  2. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease

    Molecular Metabolism, Vol. 29, pp. 40-54

2018

  1. Biomarkers in NAFLD

    Fatty liver disease: a reality with many questions (Eolas), pp. 101-133

2017

  1. Role of aramchol in steatohepatitis and fibrosis in mice

    Hepatology Communications, Vol. 1, Núm. 9, pp. 911-927

  2. The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury

    Nature Communications, Vol. 8, Núm. 1